ReviewFactors affecting sleep quality in patients with psoriasis
Section snippets
Methods
A PubMed literature search was performed in English that examined relationships between sleep quality and psoriasis using the terms “psoriasis” and “sleep.” Exclusion criteria included articles in text other than English, sleep as a medication adverse effect, quality-of-life instrument validation studies, and sleep in association with diseases other than psoriasis. Results obtained from this search revealed quality of life, pruritus, pain, depression, and sleep disorders as topics associated
Quality of life
Extensive study on quality of life in patients with psoriasis demonstrates a major impact on physical, psychologic, and social aspects of living. The use of generic, dermatologic, and psoriasis-specific quality-of-life instruments has aided in uncovering and identifying these extracutaneous manifestations of disease. The effects of psoriasis on sleep quality, however, have not been included in many of these assessments. Review of specific measures used to evaluate quality of life in patients
Discussion
Direct and indirect evidence demonstrates that sleep quality in patients with psoriasis can be adversely affected by pruritus, depression, pain, OSA, or a combination of these. Sleep difficulties caused by the association and potential overlap of these factors in patients may be attributed to similarities in cytokine and neuropeptide profiles that may act to alter sleep physiology. TNF, interleukin (IL)-6, and SP are mediators involved in psoriasis, pruritus, depression, pain, and OSA that may
References (81)
- et al.
Quality-of-life issues in psoriasis and psoriatic arthritis: outcome measures and therapies from a dermatological perspective
J Am Acad Dermatol
(2006) - et al.
Quality-of-life issues in psoriasis
Dermatol Clin
(2004) Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment
Dermatol Clin
(1996)- et al.
Quality of life in patients with psoriasis: a systematic literature review
J Investig Dermatol Symp Proc
(2004) - et al.
Psoriasis causes as much disability as other major medical diseases
J Am Acad Dermatol
(1999) - et al.
Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriasis: a pilot study
J Am Acad Dermatol
(2008) - et al.
Pruritus and nocturnal wakenings
J Am Acad Dermatol
(1990) - et al.
Disease severity, scratching, and sleep quality in patients with atopic dermatitis
J Am Acad Dermatol
(2008) - et al.
Pruritus associated with nocturnal wakenings: organic or psychogenic?
J Am Acad Dermatol
(1989) - et al.
Psychologic factors in psoriasis: consequences, mechanisms, and interventions
Dermatol Clin
(2005)
Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis–a structural equations modeling approach
Gen Hosp Psychiatry
Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults
Biol Psychiatry
Sleep pattern in an experimental model of osteoarthritis
Pain
Sleep deprivation and pain perception
Sleep Med Rev
Obstructive sleep apnea
Lancet
Comorbidities in psoriasis
Clin Dermatol
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomized phase III trial
Lancet
de KJ. Effects of etanercept on quality of life, fatigue, and depression in psoriasis
Lancet
Depression, comorbidities and the TNF-alpha system
Eur Psychiatry
Cytokine imbalance in the pathophysiology of major depressive disorder
Prog Neuropsychopharmacol Biol Psychiatry
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome
Cytokine
Hyperalgesia and allodynia: peripheral mechanisms
Joint Bone Spine
Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime
Metabolism
Substance P serum levels are increased in major depression: preliminary results
Biol Psychiatry
Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men
Neuropsychopharmacology
Relationship between serum substance P levels and daytime sleepiness in obstructive sleep apnea syndrome
Chest
Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity
J Invest Dermatol
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey
Arch Dermatol
Quality of life issues in psoriasis
J Am Acad Dermatol
Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis
J Am Acad Dermatol
Psoriasis: cardiovascular risk factors and other disease comorbidities
J Drugs Dermatol
Predictors of sleep disturbance in patients with psoriasis
J Investig Dermatol
Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis
Br J Dermatol
Mediators of pruritus in psoriasis
Mediators Inflamm
The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis
Br J Dermatol
Prevalence of symptoms experienced by patients with different clinical types of psoriasis
Br J Dermatol
Pruritus and psoriasis
Br J Dermatol
Further studies of scratching during sleep
Br J Dermatol
The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis
Arch Pediatr Adolesc Med
Cited by (91)
Sleep disturbances in patients with psoriatic arthritis
2023, Revista Colombiana de ReumatologiaSleep impairment in patients with chronic inflammatory skin diseases: A review of mechanisms and management
2023, Journal of the American Academy of DermatologyBrain structure and connectivity in psoriasis and associations with depression and inflammation; findings from the UK biobank
2022, Brain, Behavior, and Immunity - HealthInsights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities
2021, Journal of AutoimmunityCitation Excerpt :Furthermore, persistent sleep disturbance may exacerbate the severity of psoriasis, and psoriasis patients with disturbed sleep cycles are at higher risk of multiple comorbidities, including hypertension, stroke, insulin resistance and diabetes. Several factors such as pruritus, depression, pain, hypoxia and fatigue have been elucidated for deterioration of sleep quality and quantity or deprived sleep in psoriasis patients [289]. Obstructive sleep apnea (OSA) is an insidious clinical phenomenon represented by nocturnal awakenings and fitful slumber as a result of recurrent upper respiratory impediment during sleep.
Development and Initial Psychometric Properties of Two Itch-Related Measures: Scratch Intensity and Impact, Sleep-Related Itch and Scratch
2020, Journal of Investigative Dermatology
Funding for manuscript development was provided by Abbott Laboratories. The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, LP.
Disclosure: Dr Goldblum is an employee of Abbott Laboratories and owns Abbott stock. Dr McCall has served as an investigator for GlaxoSmithKline, Mini Mitter, the National Institutes of Health, Sanofi-Aventis, Sealy, Sepracor, and Somaxon, receiving research grants; has served as a consultant for AstraZeneca, Orexo AB, Sepracor, and Somaxon, receiving honoraria; and has served as a member of the speakers' bureaus for Sanofi-Aventis and Sepracor, receiving honoraria. Dr Feldman has served as an advisory board member, investigator, and speaker for Abbott Laboratories, Astellas, Galderma, Steifel, and Warner Chilcott, receiving grants and honoraria; has served on the advisory board for Photomedex, receiving stock options; has been an investigator and speaker for Amgen, Centocor, and Genentech, receiving grants and honoraria; and has served as an advisory board member and speaker for the National Psoriasis Foundation, receiving honoraria. Ms Gowda has no conflicts to declare.
Reprints not available from the author.